QLS12010 Capsules

· Shanghai Qilu Pharmaceutical Research and Development Center LTD

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QLS12010 Capsules, covering 2025-07-31 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]